The Septofimbrial Nucleus (SFN) is a distinct component of the basal forebrain septal complex, situated at the junction of the lateral septum and the nucleus of the diagonal band. The SFN receives hippocampal inputs via the fimbria and projects to hypothalamic nuclei involved in stress response, autonomic regulation, and neuroendocrine control[1].
| Taxonomy | ID | Name / Label |
|---|
The SFN contains a heterogeneous population of neurons:
The septofimbrial region shows early vulnerability in AD, with cholinergic and GABAergic neuron loss observed in the basal forebrain. The SFN participates in the septohippocampal pathway critical for memory consolidation, and its degeneration contributes to hippocampal dysfunction and memory deficits characteristic of early AD[4].
While less directly studied than other basal forebrain regions, the SFN may show dysfunction in PD due to its hypothalamic connections. Sleep disorders in PD, including REM sleep behavior disorder, may involve SFN pathology given its role in sleep-wake regulation[5].
GABAergic neuron loss in the septal complex, including the SFN, has been documented in HD and contributes to the emotional and psychiatric symptoms that precede motor manifestations[6].
Swanson, L.W. (2019). Neuroanatomical Terminology. 2019. ↩︎
Leranth, C., & Vertes, R.P. (2019). GABAergic and non-GABAergic septal neurons. Brain Research Bulletin. 2019. ↩︎
Risold, P.Y., & Swanson, L.W. (2017). Chemicoarchitectonic organization of the hypothalamus. Handbook of Clinical Neurology. 2017. ↩︎
Mesulam, M.M. (2013). Cholinergic circuitry of the human basal forebrain. Journal of Comparative Neurology. 2013. ↩︎
Jellinger, K.A. (1991). Pathology of Parkinson's disease. Journal of Neural Transmission. 1991. ↩︎
Ferrante, R.J., et al. (2002). Morphological and metabolic evidence for selective vulnerability in Huntington's disease. Journal of Neuropathology & Experimental Neurology. 2002. ↩︎